IL10 and autoimmune disease: Because MaR1 promotes the expression and production of IL-10 (Figs. 2A, S3C), which can influence Th17 pathogenicity in autoimmune disorders (32), we next investigated the immune cells that produce IL-10 in response to MaR1 treatment.